Pseudomonas aeruginosa (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pseudomonas aeruginosa" in Galician language version.

refsWebsite

Global rank Galician rank

27nih.gov

4^th place

6^th place

22doi.org

2^nd place

7^th place

10archive.org

6^th place

8^th place

1wipo.int

1,462^nd place

791^st place

1web.archive.org

1^st place

1cict.fr

low place

1,083^rd place

1horizonpress.com

low place

1,294^th place

1textbookofbacteriology.net

low place

2,871^st place

1uchicago.edu

230^th place

245^th place

1isciii.es

6,339^th place

1,318^th place

archive.org

Balcht, Aldona & Smith, Raymond (1994). Pseudomonas Aeruginosa: Infections and Treatment. Informa Health Care. pp. 83–84. ISBN 0-8247-9210-6.
Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 0-8385-8529-9.
Iglewski BH (1996). Pseudomonas. In: Baron's Medical Microbiology (Baron S et al., eds.) (4th ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1.
Hassett DJ (1996). "Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen". J. Bacteriol. 178 (24): 7322–5. PMC 178651. PMID 8955420.
Worlitzsch D; Tarran R; Ulrich M; Schwab, Ute; Cekici, Aynur; Meyer, Keith C.; Birrer, Peter; Bellon, Gabriel; Berger, Jürgen (2002). "Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients". J. Clin. Invest. 109 (3): 317–325. PMC 150856. PMID 11827991. doi:10.1172/JCI13870.
Diekema DJ; Pfaller MA; Jones RN; Doern, GV; Winokur, PL; Gales, AC; Sader, HS; Kugler, K; Beach, M (1999). "Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997". Clin. Infect. Dis. 29 (3): 595–607. PMID 10530454. doi:10.1086/598640.
Prithiviraj B, Bais H, Weir T, Suresh B, Najarro E, Dayakar B, Schweizer H, Vivanco J (2005). "Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans". Infect Immun 73 (9): 5319–5328. PMC 1231131. PMID 16113247. doi:10.1128/IAI.73.9.5319-5328.2005.
D'Argenio DA, Gallagher LA, Berg CA, Manoil C (2001). "Drosophila as a model host for Pseudomonas aeruginosa infection". J. Bacteriol. 183 (4): 1466–71. PMC 95024. PMID 11157963. doi:10.1128/JB.183.4.1466-1471.2001.
Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E (2003). "Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis". Infect. Immun. 71 (5): 2404–13. PMC 153283. PMID 12704110. doi:10.1128/IAI.71.5.2404-2413.2003.
Hachem RY; Chemaly RF; Ahmar CA; Jiang, Y.; Boktour, M. R.; Rjaili, G. A.; Bodey, G. P.; Raad, I. I. (2007). "Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients". Antimicrob. Agents Chemother. 51 (6): 1905–11. PMC 1891378. PMID 17387153. doi:10.1128/AAC.01015-06.

cict.fr

bacterio.cict.fr

"List of Prokaryotic Names with Standing in Nomenclature". Arquivado dende o orixinal o 06 de decembro de 2006. Consultado o 26 de abril de 2013.

doi.org

dx.doi.org

A. Y. Itah and J. P. Essien (2005). "Growth Profile and Hydrocarbonoclastic Potential of Microorganisms Isolated from Tarballs in the Bight of Bonny, Nigeria". World Journal of Microbiology and Biotechnology 21 (6–7): 1317–22. doi:10.1007/s11274-004-6694-z.
Anzai; Kim, H; Park, JY; Wakabayashi, H; Oyaizu, H (2000, Jul). "Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence". Int J Syst Evol Microbiol 50 (4): 1563–89. PMID 10939664. doi:10.1099/00207713-50-4-1563.
Palmer KL, Brown SA, Whiteley M (2007). "Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum". J. Bacteriol. 189 (12): 4449–55. PMC 1913347. PMID 17400735. doi:10.1128/JB.00162-07.
Worlitzsch D; Tarran R; Ulrich M; Schwab, Ute; Cekici, Aynur; Meyer, Keith C.; Birrer, Peter; Bellon, Gabriel; Berger, Jürgen (2002). "Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients". J. Clin. Invest. 109 (3): 317–325. PMC 150856. PMID 11827991. doi:10.1172/JCI13870.
Cooper M, Tavankar GR, Williams HD (2003). "Regulation of expression of the cyanide-insensitive terminal oxidase in Pseudomonas aeruginosa". Microbiology 149 (Pt 5): 1275–84. PMID 12724389. doi:10.1099/mic.0.26017-0.
Williams HD, Zlosnik JE, Ryall B (2007). "Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa". Adv. Microb. Physiol. 52: 1–71. PMID 17027370. doi:10.1016/S0065-2911(06)52001-6.
Fine MJ; Smith MA; Carson CA; Mutha, SS; Sankey, SS; Weissfeld, LA; Kapoor, WN (1996). "Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis". JAMA 275 (2): 134–141. PMID 8531309. doi:10.1001/jama.275.2.134.
Diekema DJ; Pfaller MA; Jones RN; Doern, GV; Winokur, PL; Gales, AC; Sader, HS; Kugler, K; Beach, M (1999). "Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997". Clin. Infect. Dis. 29 (3): 595–607. PMID 10530454. doi:10.1086/598640.
Prithiviraj B, Bais H, Weir T, Suresh B, Najarro E, Dayakar B, Schweizer H, Vivanco J (2005). "Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans". Infect Immun 73 (9): 5319–5328. PMC 1231131. PMID 16113247. doi:10.1128/IAI.73.9.5319-5328.2005.
Walker TS; Bais HP; Déziel E; Schweizer, HP; Rahme, LG; Fall, R; Vivanco, JM (2004). "Pseudomonas aeruginosa-plant root interactions. Pathogenicity, biofilm formation, and root exudation". Plant Physiol. 134 (1): 320–331. PMC 316311. PMID 14701912. doi:10.1104/pp.103.027888.
Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM (1995). "Common virulence factors for bacterial pathogenicity in plants and animals". Science 268 (5219): 1899–1902. PMID 7604262. doi:10.1126/science.7604262.
Rahme LG; Tan MW; Le L; Wong, SM; Tompkins, RG; Calderwood, SB; Ausubel, FM (1997). "Use of model plant hosts to identify Pseudomonas aeruginosa virulence factors". Proc. Natl. Acad. Sci. U.S.A. 94 (24): 13245–50. PMC 24294. PMID 9371831. doi:10.1073/pnas.94.24.13245.
Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM (1999). "Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model". Cell 96 (1): 47–56. PMID 9989496. doi:10.1016/S0092-8674(00)80958-7.
Martínez C, Pons E, Prats G, León J (2004). "Salicylic acid regulates flowering time and links defence responses and reproductive development". Plant J. 37 (2): 209–17. PMID 14690505. doi:10.1046/j.1365-313X.2003.01954.x.
D'Argenio DA, Gallagher LA, Berg CA, Manoil C (2001). "Drosophila as a model host for Pseudomonas aeruginosa infection". J. Bacteriol. 183 (4): 1466–71. PMC 95024. PMID 11157963. doi:10.1128/JB.183.4.1466-1471.2001.
Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E (2003). "Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis". Infect. Immun. 71 (5): 2404–13. PMC 153283. PMID 12704110. doi:10.1128/IAI.71.5.2404-2413.2003.
Rahme LG; Ausubel FM; Cao H; Drenkard, E; Goumnerov, BC; Lau, GW; Mahajan-Miklos, S; Plotnikova, J; Tan, MW (2000). "Plants and animals share functionally common bacterial virulence factors". Proc. Natl. Acad. Sci. U.S.A. 97 (16): 8815–21. PMC 34017. PMID 10922040. doi:10.1073/pnas.97.16.8815.
Thomas Bjarnsholt,1 Peter Østrup Jensen,2 Thomas B. Rasmussen,1 Lars Christophersen,2 Henrik Calum,2 Morten Hentzer,3 Hans-Petter Hougen,4 Jørgen Rygaard,5 Claus Moser,2 Leo Eberl,6 Niels Høiby2 and Michael Givskov1 (2005). "Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections". Microbiology 151 (4): 3873–80. PMID 16339933. doi:10.1099/mic.0.27955-0.
A. Sulakvelidze, Z. Alavidze and J.G. Morris, Jr. (2001). "Bacteriophage therapy". Antimicrobial Agents and Chemotherapy 45 (3): 649–659. PMC 90351. PMID 11181338. doi:10.1128/AAC.45.3.649-659.2001.
Hachem RY; Chemaly RF; Ahmar CA; Jiang, Y.; Boktour, M. R.; Rjaili, G. A.; Bodey, G. P.; Raad, I. I. (2007). "Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients". Antimicrob. Agents Chemother. 51 (6): 1905–11. PMC 1891378. PMID 17387153. doi:10.1128/AAC.01015-06.
Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, de Champs C. (2008). "Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in ICU-patients". Crit Care 12 (3): R69. PMC 2481460. PMID 18489775. doi:10.1186/cc6907.
Döring G, Pier GB (2008). "Vaccines and immunotherapy against Pseudomonas aeruginosa". Vaccine 26 (8): 1011–24. PMID 18242792. doi:10.1016/j.vaccine.2007.12.007.

horizonpress.com

Cornelis P (editor). (2008). Pseudomonas: Genomics and Molecular Biology (1st ed.). Caister Academic Press. ISBN 1-904455-19-0.

isciii.es

scielo.isciii.es

Pseudomonas aeruginosa: tratamiento combinado frente a monoterapia. Med. Intensiva v.31 n.2 Madrid mar. 2007. [2]

nih.gov

ncbi.nlm.nih.gov

Anzai; Kim, H; Park, JY; Wakabayashi, H; Oyaizu, H (2000, Jul). "Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence". Int J Syst Evol Microbiol 50 (4): 1563–89. PMID 10939664. doi:10.1099/00207713-50-4-1563.
King EO, Ward MK, Raney DE (1954). "Two simple media for the demonstration of pyocyanin and fluorescein". J Lab Clin Med 44 (2): 301–7. PMID 13184240.
Palmer KL, Brown SA, Whiteley M (2007). "Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum". J. Bacteriol. 189 (12): 4449–55. PMC 1913347. PMID 17400735. doi:10.1128/JB.00162-07.
Vander Wauven C, Piérard A, Kley-Raymann M, Haas D (1984). "Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway". J. Bacteriol. 160 (3): 928–34. PMC 215798. PMID 6438064.
Hassett DJ (1996). "Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen". J. Bacteriol. 178 (24): 7322–5. PMC 178651. PMID 8955420.
Worlitzsch D; Tarran R; Ulrich M; Schwab, Ute; Cekici, Aynur; Meyer, Keith C.; Birrer, Peter; Bellon, Gabriel; Berger, Jürgen (2002). "Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients". J. Clin. Invest. 109 (3): 317–325. PMC 150856. PMID 11827991. doi:10.1172/JCI13870.
Cooper M, Tavankar GR, Williams HD (2003). "Regulation of expression of the cyanide-insensitive terminal oxidase in Pseudomonas aeruginosa". Microbiology 149 (Pt 5): 1275–84. PMID 12724389. doi:10.1099/mic.0.26017-0.
Williams HD, Zlosnik JE, Ryall B (2007). "Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa". Adv. Microb. Physiol. 52: 1–71. PMID 17027370. doi:10.1016/S0065-2911(06)52001-6.
Mathee, K.; Narasimhan, G.; Valdes, C.; Qiu, X.; Matewish, J. M.; Koehrsen, M.; Rokas, A.; Yandava, C. N. et al. (2008). "Dynamics of Pseudomonas aeruginosa genome evolution". Proceedings of the National Academy of Sciences 105 (8): 3100–3105. doi:10.1073/pnas.0711982105. PMC 2268591. PMID 18287045.
Fine MJ; Smith MA; Carson CA; Mutha, SS; Sankey, SS; Weissfeld, LA; Kapoor, WN (1996). "Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis". JAMA 275 (2): 134–141. PMID 8531309. doi:10.1001/jama.275.2.134.
Diekema DJ; Pfaller MA; Jones RN; Doern, GV; Winokur, PL; Gales, AC; Sader, HS; Kugler, K; Beach, M (1999). "Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997". Clin. Infect. Dis. 29 (3): 595–607. PMID 10530454. doi:10.1086/598640.
Prithiviraj B, Bais H, Weir T, Suresh B, Najarro E, Dayakar B, Schweizer H, Vivanco J (2005). "Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans". Infect Immun 73 (9): 5319–5328. PMC 1231131. PMID 16113247. doi:10.1128/IAI.73.9.5319-5328.2005.
Walker TS; Bais HP; Déziel E; Schweizer, HP; Rahme, LG; Fall, R; Vivanco, JM (2004). "Pseudomonas aeruginosa-plant root interactions. Pathogenicity, biofilm formation, and root exudation". Plant Physiol. 134 (1): 320–331. PMC 316311. PMID 14701912. doi:10.1104/pp.103.027888.
Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM (1995). "Common virulence factors for bacterial pathogenicity in plants and animals". Science 268 (5219): 1899–1902. PMID 7604262. doi:10.1126/science.7604262.
Rahme LG; Tan MW; Le L; Wong, SM; Tompkins, RG; Calderwood, SB; Ausubel, FM (1997). "Use of model plant hosts to identify Pseudomonas aeruginosa virulence factors". Proc. Natl. Acad. Sci. U.S.A. 94 (24): 13245–50. PMC 24294. PMID 9371831. doi:10.1073/pnas.94.24.13245.
Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM (1999). "Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model". Cell 96 (1): 47–56. PMID 9989496. doi:10.1016/S0092-8674(00)80958-7.
Martínez C, Pons E, Prats G, León J (2004). "Salicylic acid regulates flowering time and links defence responses and reproductive development". Plant J. 37 (2): 209–17. PMID 14690505. doi:10.1046/j.1365-313X.2003.01954.x.
D'Argenio DA, Gallagher LA, Berg CA, Manoil C (2001). "Drosophila as a model host for Pseudomonas aeruginosa infection". J. Bacteriol. 183 (4): 1466–71. PMC 95024. PMID 11157963. doi:10.1128/JB.183.4.1466-1471.2001.
Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E (2003). "Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis". Infect. Immun. 71 (5): 2404–13. PMC 153283. PMID 12704110. doi:10.1128/IAI.71.5.2404-2413.2003.
Rahme LG; Ausubel FM; Cao H; Drenkard, E; Goumnerov, BC; Lau, GW; Mahajan-Miklos, S; Plotnikova, J; Tan, MW (2000). "Plants and animals share functionally common bacterial virulence factors". Proc. Natl. Acad. Sci. U.S.A. 97 (16): 8815–21. PMC 34017. PMID 10922040. doi:10.1073/pnas.97.16.8815.
Thomas Bjarnsholt,1 Peter Østrup Jensen,2 Thomas B. Rasmussen,1 Lars Christophersen,2 Henrik Calum,2 Morten Hentzer,3 Hans-Petter Hougen,4 Jørgen Rygaard,5 Claus Moser,2 Leo Eberl,6 Niels Høiby2 and Michael Givskov1 (2005). "Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections". Microbiology 151 (4): 3873–80. PMID 16339933. doi:10.1099/mic.0.27955-0.
A. Sulakvelidze, Z. Alavidze and J.G. Morris, Jr. (2001). "Bacteriophage therapy". Antimicrobial Agents and Chemotherapy 45 (3): 649–659. PMC 90351. PMID 11181338. doi:10.1128/AAC.45.3.649-659.2001.
Wright, A.; Hawkins, C.; Anggård, E.; Harper, D. (2009). "A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy". Clinical Otolaryngology 34 (4): 349–357. doi:10.1111/j.1749-4486.2009.01973.x. PMID 19673983.
Hachem RY; Chemaly RF; Ahmar CA; Jiang, Y.; Boktour, M. R.; Rjaili, G. A.; Bodey, G. P.; Raad, I. I. (2007). "Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients". Antimicrob. Agents Chemother. 51 (6): 1905–11. PMC 1891378. PMID 17387153. doi:10.1128/AAC.01015-06.
Poole, K. (2004). "Efflux-mediated multiresistance in Gram-negative bacteria". Clinical Microbiology and Infection 10 (1): 12–26. doi:10.1111/j.1469-0691.2004.00763.x. PMID 14706082.
Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, de Champs C. (2008). "Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in ICU-patients". Crit Care 12 (3): R69. PMC 2481460. PMID 18489775. doi:10.1186/cc6907.
Döring G, Pier GB (2008). "Vaccines and immunotherapy against Pseudomonas aeruginosa". Vaccine 26 (8): 1011–24. PMID 18242792. doi:10.1016/j.vaccine.2007.12.007.

textbookofbacteriology.net

Todar's Online Textbook of Bacteriology. Textbookofbacteriology.net (2004-06-04). Retrieved on 2011-10-09.

uchicago.edu

news.uchicago.edu

Research could lead to new non-antibiotic drugs to counter hospital infections. University of Chicago Medical Center. 2009-04-14. Acceso 26-04-2013. [1]

web.archive.org

"List of Prokaryotic Names with Standing in Nomenclature". Arquivado dende o orixinal o 06 de decembro de 2006. Consultado o 26 de abril de 2013.

wipo.int

patentscope.wipo.int

AVI Biopharma (2007-01-18). "Antisense antibacterial method and compound". World Intellectual Property Organization. Consultado o 2008-10-18.